These findings imply that peiminine may have potential anti-tumor activity by downregulating the PI3K–Akt signaling pathway and upregulating pro-apoptotic genes, leading to reduced cell proliferation and increased apoptosis in cancer cells, providing a basis for further investigation into its mechanism of action and potential applications in cancer treatment. Here, AKT1 is linked to neoplasm.